Clinical Research
The Stanford Thoracic Oncology team is engaged in cutting-edge research and offers a wide number and variety of clinical trials incorporating novel treatments for both early and advanced-stage lung cancers.
Clinical Research Highlights:
- Combination trials with surgery, radiation and drug therapy
- Immune therapy (cancer vaccine) as an adjuvant to surgery
- Dendritic cell vaccines and autologous tumor cell vaccines
- New combinations of oral agents that counteract resistance to targeted therapies
- Advanced imaging, motion control and delivery of radiation therapy
- Stereotactic radiotherapy and targeted inhibitors for lung cancer metastases to the brain
- Molecular analysis of lung and thymic tumors
Find clinical trials for patients with advanced lung disease.
Trial Administration